Mata DG

General

Full name : Mata David G

First name : David G

Mail : USAMRICD\/ORISE. Aberdeen Proving Ground, MD

Zip Code :

City :

Country : USA

Email :

Phone :

Fax :

Website :

Directory :

References (3)

Title : Assessing the stoichiometric efficacy of mammalian expressed paraoxonase-1 variant I-F11 to afford protection against G-type nerve agents - Mata_2016_Chem.Biol.Interact_259_233
Author(s) : Mata DG , Sabnekar P , Watson CA , Rezk PE , Chilukuri N
Ref : Chemico-Biological Interactions , 259 :233 , 2016
Abstract : Mata_2016_Chem.Biol.Interact_259_233
ESTHER : Mata_2016_Chem.Biol.Interact_259_233
PubMedSearch : Mata_2016_Chem.Biol.Interact_259_233
PubMedID: 27083144

Title : An in vitro and in vivo evaluation of the efficacy of recombinant human liver prolidase as a catalytic bioscavenger of chemical warfare nerve agents - Rezk_2015_Drug.Chem.Toxicol_38_37
Author(s) : Rezk PE , Zdenka P , Sabnekar P , Kajih T , Mata DG , Wrobel C , Cerasoli DM , Chilukuri N
Ref : Drug & Chemical Toxicology , 38 :37 , 2015
Abstract : Rezk_2015_Drug.Chem.Toxicol_38_37
ESTHER : Rezk_2015_Drug.Chem.Toxicol_38_37
PubMedSearch : Rezk_2015_Drug.Chem.Toxicol_38_37
PubMedID: 24641262

Title : Investigation of evolved paraoxonase-1 variants for prevention of organophosphorous pesticide compound intoxication - Mata_2014_J.Pharmacol.Exp.Ther_349_549
Author(s) : Mata DG , Rezk PE , Sabnekar P , Cerasoli DM , Chilukuri N
Ref : Journal of Pharmacology & Experimental Therapeutics , 349 :549 , 2014
Abstract : Mata_2014_J.Pharmacol.Exp.Ther_349_549
ESTHER : Mata_2014_J.Pharmacol.Exp.Ther_349_549
PubMedSearch : Mata_2014_J.Pharmacol.Exp.Ther_349_549
PubMedID: 24706983